|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS12241 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-Slit1/MEGF4 |
| 克隆性 | 是 |
| 靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
| 適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
| 形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
| 宿主 | 詳見(jiàn)說(shuō)明書(shū) |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from human Slit1/MEGF4 (455-500aa) |
全、新、優(yōu)、品、好四大特點(diǎn)：
多重表皮生長(zhǎng)因子樣蛋白4抗體費(fèi)用 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
多重表皮生長(zhǎng)因子樣蛋白4抗體費(fèi)用 英文名稱 Anti-Slit1/MEGF4
中文名稱 多重表皮生長(zhǎng)因子樣蛋白4抗體費(fèi)用
別 名 MEGF 4; MEGF4; Multiple EGF like domains protein 4; Multiple epidermal growth factor like domains 4; Multiple epidermal growth factor like domains protein 4; SLIL 1; SLIL1; Slit 1; SLIT 3; Slit homolog 1; Slit homolog 1 protein; Slit-1; Slit1; SLIT3; KIAA0813; SLIT1_HUMAN.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Cow, Horse, Rabbit, Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 發(fā)育生物學(xué) 神經(jīng)生物學(xué)
蛋白分子量 predicted molecular weight: 164kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Slit1/MEGF4 (455-500aa)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
多重表皮生長(zhǎng)因子樣蛋白4抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Secreted leucine-rich repeat-containing proteins 1-3 (Slit1-3) are secreted glycoproteins that influence axonal guidance and mediate normal neural development by acting as high-affinity signaling ligands for the repulsive guidance receptor, Roundabout (Robo) (1, 2). Within the developing central nervous system (CNS) of different vertebrate systems, Slit proteins are expressed in equivalent regions, suggesting a conserved function among vertebrate homologs (3,4). Slit is expressed in the midline of the central nervous system in both vertebrates and invertebrates, where it functions as a regulatory factor of mesodermal cell movement during gastrulation (5). Slit2 is a short range inhibitory guidance cue for retinal ganglion cell (RGC) axons that may mediate spatial progression of RGCs (6,7).
Function : Thought to act as molecular guidance cue in cellular migration, and function appears to be mediated by interaction with roundabout homolog receptors. During neural development involved in axonal navigation at the ventral midline of the neural tube and projection of axons to different regions (By similarity). SLIT1 and SLIT2 together seem to be essential for midline guidance in the forebrain by acting as repulsive signal preventing inappropriate midline crossing by axons projecting from the olfactory bulb.
Subunit : Interacts with ROBO1 and GREM1
Subcellular Location : Secreted.
Tissue Specificity : Predominantly expressed in adult forebrain. Expressed in fetal brain, lung and kidney.
Similarity : Contains 1 CTCK (C-terminal cystine knot-like) domain.
Contains 9 EGF-like domains.
Contains 1 laminin G-like domain.
Contains 20 LRR (leucine-rich) repeats.
Contains 4 LRRCT domains.
Contains 4 LRRNT domains.
Database links : UniProtKB/Swiss-Prot: O75093.4
實(shí)驗(yàn)流程：
正在熱銷(xiāo)的相關(guān)產(chǎn)品：
四肽重復(fù)同源框1 多克隆抗體 TPRX1 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
TAP結(jié)合蛋白(甲巰蛋白) 多克隆抗體 TPSN Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
跨膜磷酸肌醇-3-磷酸酶張力蛋白同源物2 多克隆抗體 TPTE2 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
受體超族,成員13C 多克隆抗體 TR13C Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
甲狀腺素受體關(guān)聯(lián)蛋白3 多克隆抗體 TR150 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
ASMTL蛋白抗體 整合素αVβ3抗體
心素抗體 整合素αVβ1抗體
嗜酸粒細(xì)胞趨化蛋白22抗體 整合素αM抗體Integrin αM
病毒核結(jié)合蛋白-1抗體 整合素αM/巨噬細(xì)胞表面分子抗體
細(xì)胞酪氨酸轉(zhuǎn)氨酶抗體 整合素αL抗體Integrin αL
血小板源性生長(zhǎng)因子AA+BB抗體 MYOZ抗體
PDZ結(jié)構(gòu)域PDZK9蛋白抗體 myocardin相關(guān)轉(zhuǎn)錄因子抗體
脂滴包被蛋白A+B抗體 MYC誘導(dǎo)線粒體蛋白抗體
原鈣粘蛋白β5抗體 MYC啟動(dòng)子結(jié)合蛋白1抗體
小鼠抗萊克多巴胺單克隆抗體 MYC結(jié)合蛋白2抗體
安石榴 Punica granatum Linn. Punicalagin 安石榴苷 65995-63-3 C48H28O30 ≥98%
白花前胡醇WhitqQicnHuChunHPLC≥98%;20mg/支
丹參同IIA-磺酸 Sulfotanshinone wo7ium Injection 69659-80-9 20mg HPLC≥98% 用于含量測(cè)定
含量測(cè)定鹽酸安溴索100599-200502常溫，避光100mg
Cellulose Acetate醋酸纖維素標(biāo)準(zhǔn)品9004-35-7125mg
多重表皮生長(zhǎng)因子樣蛋白4抗體費(fèi)用本甲酰新烏頭原堿 Benzoylmesaconine 分 子 量：589.6700 CAS編號(hào)：63238-67-5 分子式：589.67 別 名：本甲酰中烏頭原堿 【作用與用途】本品用于含量測(cè)定。
云南含笑Michelia yunnanensis Roseoside 長(zhǎng)壽花糖甙 54835-70-0 C19H30O8 模擬天然水CODMn溶液成分分析標(biāo)準(zhǔn)物質(zhì)080427
含量測(cè)定醋酸曲安奈德 10125- 200404常溫，避光50mg
Dietxylcarbam Ciate枸櫞酸嗪標(biāo)準(zhǔn)品1642-54-2200mg
麻風(fēng)樹(shù)Jaopha curcas 13-metxyl-8,11,13-podocarpaiene-3,12-diol 13-甲基-8,11,13-羅漢松科-3,12-二醇 769140-74-1 C18H26O2 Unstable
技術(shù)外包服務(wù):
★多重表皮生長(zhǎng)因子樣蛋白4抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
|
